(Q54541649)

31 May 2018

title

FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis. (English)

1 reference

31 May 2018

author name string

L Groesser

1

1 reference

31 May 2018

E Herschberger

2

1 reference

31 May 2018

M Landthaler

3

1 reference

31 May 2018

C Hafner

4

1 reference

31 May 2018

language of work or name

English

0 references

publication date

14 March 2012

1 reference

31 May 2018

British Journal of Dermatology

published in

1 reference

31 May 2018

volume

166

1 reference

31 May 2018

issue

4

1 reference

31 May 2018

page(s)

784-788

1 reference

31 May 2018

Benign lichenoid keratosis: a clinical and pathologic reappraisal of 1040 cases.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Lichenoid keratosis: a clinicopathologic study of 17 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Lentigo Senilis And Its Evolutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Rare cancer-specific mutations in PIK3CA show gain of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

PIK3CA mutation associates with improved outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

Hot-spot mutations in p110alpha of phosphatidylinositol 3-kinase (pI3K): differential interactions with the regulatory subunit p85 and with RAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10788.X

10.1111/J.1365-2133.2011.10788.X

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018